NodeAI Diagnostics

AIDigital Health & HealthTechHamilton, ON

Hamilton company building an AI decision-support platform that gives real-time lymph-node staging guidance for lung cancer during EBUS-TBNA ultrasound procedures.

The Toronto skyline and the CN Tower at sunset, seen across Lake Ontario.

Canadian innovation builds a brighter tomorrow.

About

Company site: nodeai.ca

Hamilton company building an AI decision-support platform that gives real-time lymph-node staging guidance for lung cancer during EBUS-TBNA ultrasound procedures.

  • Federal corporation NodeAI Diagnostics Corp. (Juri ID 1547870-7), status Active, registered office in Hamilton, Ontario. ised-isde.canada.ca

  • Site is 175 Longwood Road S #113, Hamilton, ON, L8P 0A1 — the address its own site lists. nodeai.ca

  • Closed an oversubscribed pre-seed funding round, announced January 2025; amount not disclosed. innovationfactory.ca

  • Runs 6 active multi-centre clinical trial sites for its platform, with 9 more in activation, ahead of FDA/Health Canada clearance. nodeai.ca

Products & Services

Company site: nodeai.ca

Products NodeAI Diagnostics publishes on its own site. Each card links to the page it was taken from.

NodeAI EBUS Decision Support

AI diagnostic decision support

Company describes near-real-time AI decision support for lung-cancer lymph-node detection, station identification and malignancy prediction during EBUS-TBNA, via plug-in hardware built on a proprietary dataset of 3.2M+ ultrasound images and videos paired to pathology data.

Learn more

Funding & Investors

Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.

  1. Pre-seed

    Jan 25, 2025

    Investors: McMaster Seed Fund

Latest: Pre-seed · Jan 25, 2025

Government & Grants

Government support actually received. Unpublished amounts are left out.

  1. Industrial Research Assistance Program, National Research Council Canada

  2. Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada

Recent News

  1. Jan 25, 2025Funding

    NodeAI attains oversubscribed pre-seed funding round

    NodeAI closed an oversubscribed pre-seed funding round to accelerate development of its real-time AI lung-cancer lymph-node staging technology, with support from the McMaster Seed Fund.

People

Sourced from the company's own pages or announcements.

Mackensey Bacon

Chief Executive Officer

Anthony Gatti

Co-Founder and Chief Technical Officer

Wael Hanna

Co-Founder and Chief Medical Officer

Technology Focus

Company site: nodeai.ca

Terms the company uses about its own work.

AI decision supportEBUS-TBNALung cancer stagingMachine learning

Similar Companies

Other companies in AI.

Join Canada’s innovation community.

Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.

624
Verified Companies
45
Funding Opportunities
19
Sectors
A stronger Canada together